Artax Biopharma

Artax Biopharma, led by CEO Joseph Lobacki, is a biotechnology company focused on the science of immune modulation for autoimmune diseases. It has developed an innovative small-molecule approach to treat autoimmune conditions by modulating the immune system to address these diseases while allowing the body to defend against foreign pathogens. The company is researching a first-in-class oral immunomodulator as a new method to treat various autoimmune diseases without causing the immunosuppression typically associated with currently available autoimmune therapies.